help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Couce, M.
Right arrow Articles by Butler, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Couce, M.
Right arrow Articles by Butler, P. C.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 1267-1272, Copyright © 1996 by Endocrine Society

ARTICLES

Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis

M Couce, TD O'Brien, A Moran, PC Roche and PC Butler
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.

A high proportion of patients with cystic fibrosis (CF) develop diabetes mellitus. In common with type II diabetes mellitus, diabetes mellitus in CF is characterized by a progressive decline in beta-cell function and an approximately 50% decline in beta-cell mass. It is not known whether islet amyloidosis (characteristic of type II diabetes mellitus) is present in diabetes mellitus complicating CF. To address this, pancreatic samples were obtained at autopsy from 9 control cases (without CF) and 41 cases of CF that were, in turn, subdivided into 13 nondiabetic, 12 borderline diabetic, and 16 diabetic cases based on clinical criteria. Islet amyloid was detected by light microscopy in 69% cases of CF with diabetes mellitus, 17% of cases with borderline diabetes mellitus, and none of the nondiabetic cases. Islet amyloid was not present in any of the control cases. Islet amyloidosis derived from islet amyloid polypeptide is a characteristic feature of diabetes mellitus in CF as well as type II diabetes mellitus.


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
L. Haataja, T. Gurlo, C. J. Huang, and P. C. Butler
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Endocr. Rev., May 1, 2008; 29(3): 303 - 316.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C.-j. Huang, L. Haataja, T. Gurlo, A. E. Butler, X. Wu, W. C. Soeller, and P. C. Butler
Induction of endoplasmic reticulum stress-induced -cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1656 - E1662.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
V. Preumont, M. P. Hermans, P. Lebecque, and M. Buysschaert
Glucose Homeostasis and Genotype-Phenotype Interplay in Cystic Fibrosis Patients With CFTR Gene {Delta}F508 Mutation
Diabetes Care, May 1, 2007; 30(5): 1187 - 1192.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. G. Geisler, W. Zawalich, K. Zawalich, J. R.T. Lakey, H. Stukenbrok, A. J. Milici, and W. C. Soeller
Estrogen Can Prevent or Reverse Obesity and Diabetes in Mice Expressing Human Islet Amyloid Polypeptide
Diabetes, July 1, 2002; 51(7): 2158 - 2169.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Moran, J. Phillips, and C. Milla
Insulin and Glucose Excursion Following Premeal Insulin Lispro or Repaglinide in Cystic Fibrosis-Related Diabetes
Diabetes Care, October 1, 2001; 24(10): 1706 - 1710.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Moran, C. Milla, R. Ducret, and K. S. Nair
Protein Metabolism in Clinically Stable Adult Cystic Fibrosis Patients With Abnormal Glucose Tolerance
Diabetes, June 1, 2001; 50(6): 1336 - 1343.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society